National Academy of Science advises caution when using CRISPR in the human germline

Joel Achenback, 14 February 2017 The Washington Post,

A panel convened by the National Academy of Sciences has released a report on the potential uses of CRISPR/Cas technology in humans.  The panel strongly condemned the use of CRISPR/Cas technology for cosmetic enhancement, but embraced CRISPR use for basic research and somatic genome editing for treatment of disease.  The panel did recommend caution, but left the door open to germline editing for the treatment of disease only if there is significant oversight and the disease is not treatable by conventional means.  A summary of the report can be found at:

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply